Brief: Shenzhen Neptunus Interlong Bio-Technique Updates On Unit's SODIUM BICARBONATE TABLETS
09/04/2019 15:47
April 9 (Reuters) - Shenzhen Neptunus Interlong
Bio-technique Co Ltd 8329.HK :
* UNIT GETS "DRUG APPROVAL DOCUMENT IN RESPECT OF
SUPPLEMENTAL
APPLICATION" OF "SODIUM BICARBONATE TABLETS"
* UNIT GETS DRUG APPROVAL DOCUMENT APPROVED AND ISSUED BY
NATIONAL
MEDICAL PRODUCTS ADMINISTRATION
Source text for Eikon: ID:nHKS795lcS
Further company coverage: 8329.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million